Abstract
Vancomycin is the primary antibiotic administered for treatment of methicillinresistant S. aureus (MRSA) infection; however, treatment failure of vancomycin is currently not uncommon in patients with in vitro vancomycin susceptibile S. aureus (MIC ≤ 2 μg/mL) infection. In this report, we describe a case of septic arthritis caused by persistent MRSA bacteremia and treated successfully with linezolid after failure of initial vancomycin therapy.
| Original language | English |
|---|---|
| Pages (from-to) | 403-406 |
| Number of pages | 4 |
| Journal | Infection and Chemotherapy |
| Volume | 44 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - 2012 Dec 1 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Infectious Diseases
- Pharmacology (medical)
Cite this
}
A Case of Septic Arthritis Caused by Persistent MRSA Bacteremia with Successful Treatment Through Linezolid. / Kim, Sun Bean; Oh, Dong Hyun; Kim, Yong Chan; Kim, Min Hyung; Song, Je Eun; Ahn, Jin Young; Jeong, Su Jin; Goo, Nam Su; Kim, Hye Won; Han, Sang Hoon; Choi, JunYong; Song, Young Goo; Kim, June Myung.
In: Infection and Chemotherapy, Vol. 44, No. 5, 01.12.2012, p. 403-406.Research output: Contribution to journal › Article
TY - JOUR
T1 - A Case of Septic Arthritis Caused by Persistent MRSA Bacteremia with Successful Treatment Through Linezolid
AU - Kim, Sun Bean
AU - Oh, Dong Hyun
AU - Kim, Yong Chan
AU - Kim, Min Hyung
AU - Song, Je Eun
AU - Ahn, Jin Young
AU - Jeong, Su Jin
AU - Goo, Nam Su
AU - Kim, Hye Won
AU - Han, Sang Hoon
AU - Choi, JunYong
AU - Song, Young Goo
AU - Kim, June Myung
PY - 2012/12/1
Y1 - 2012/12/1
N2 - Vancomycin is the primary antibiotic administered for treatment of methicillinresistant S. aureus (MRSA) infection; however, treatment failure of vancomycin is currently not uncommon in patients with in vitro vancomycin susceptibile S. aureus (MIC ≤ 2 μg/mL) infection. In this report, we describe a case of septic arthritis caused by persistent MRSA bacteremia and treated successfully with linezolid after failure of initial vancomycin therapy.
AB - Vancomycin is the primary antibiotic administered for treatment of methicillinresistant S. aureus (MRSA) infection; however, treatment failure of vancomycin is currently not uncommon in patients with in vitro vancomycin susceptibile S. aureus (MIC ≤ 2 μg/mL) infection. In this report, we describe a case of septic arthritis caused by persistent MRSA bacteremia and treated successfully with linezolid after failure of initial vancomycin therapy.
UR - http://www.scopus.com/inward/record.url?scp=84872871311&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84872871311&partnerID=8YFLogxK
U2 - 10.3947/ic.2012.44.5.403
DO - 10.3947/ic.2012.44.5.403
M3 - Article
VL - 44
SP - 403
EP - 406
JO - Infection and Chemotherapy
JF - Infection and Chemotherapy
SN - 2093-2340
IS - 5
ER -